US Patent 10202348 Compositions and methods of treating retinal disease
Patent 10202348 was granted and assigned to Aldeyra Therapeutics on February, 2019 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 10202348 Compositions and methods of treating retinal disease
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
